Fraction 1 CIRJP inhibits extracellular Aβ1-40 and Aβ1-42 accumulation in N2a/APP695 cells.Several RJP fractions were separated from crude RJPs via the HPLC method. We chose the 1 CI fraction as theactive ingredient after preliminary functional verification. Our results showed that 1 CI RJP below 40 μg·ml-1 didnot affect N2a and N2a/APP695 cell viability during 48 hours (Fig. 3). Compared with N2a cells, N2a/APP695cells produced a large amount of extracellular Aβ1-40 and Aβ1-42. As shown in Fig. 4, N2a/APP695 cells culturedfor 48 hours with fresh medium secreted Aβ1-40 (666.53 ± 29.48 pg/mg protein) and Aβ1-42 (180.19 ± 9.02 pg/mgprotein), as measured through an Aβ ELISA analysis. On the other hand, no exogenous Aβ1-40 and Aβ1-42 wasdetected in N2a cell medium after the cells were cultured for 48 hours. At the concentration of 9 μg·ml-1, 1 CI RJPreduced the Aβ1-40 level from 666.53 ± 29.48 pg/mg to 523.71 ± 31.42 pg/mg protein (P < 0.01, Fig. 4A) and theAβ1-42 level from 180.19 ± 9.02 pg/mg to 120.39 ± 8.60 pg/mg protein (P < 0.001, Fig. 4B), in N2a/App695 cellsmedium. These results suggest that 1 CI RJP affects Aβ metabolism in N2a/APP695 cells.